Evidence map›Paper›PMID 41442229›Full record

ArticleUnited European gastroenterology journal2026

Integrated Multi-Omic Analysis Identifies Altered Colonic Brush Border Profile as a Key Feature of Microscopic Colitis.

Danila Guagnozzi, Ana Maria Gonzalez-Castro, Yamile Zabana, Fernando Fernández-Bañares, Andreas Münch, Eva Tristan, Juan-José Lozano, Julia Sidorova, Beatriz Lobo, Carmen Alonso-Cotoner and 9 more

Abstract read
In one paragraph

Article in United European gastroenterology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Danila GuagnozziLaboratory of Neuro-immuno-gastroenterology, Vall d'Hebron Institut de Recerca, Barcelona, Spain.ORCID https://orcid.org/0000-0002-6171-1901
Ana Maria Gonzalez-CastroLaboratory of Neuro-immuno-gastroenterology, Vall d'Hebron Institut de Recerca, Barcelona, Spain.ORCID https://orcid.org/0000-0003-3955-3318
Yamile ZabanaCentro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBER-EHD), Madrid, Spain.ORCID https://orcid.org/0000-0003-4023-8868
Fernando Fernández-BañaresCentro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBER-EHD), Madrid, Spain.
Andreas MünchGastroenterology Department, Linköping University, Linköping, Sweden.ORCID https://orcid.org/0000-0003-4703-581X
Eva TristanGastroenterology Department, University Hospital Mutua de Terrassa, Barcelona, Spain.
Juan-José LozanoCentro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBER-EHD), Madrid, Spain.
Julia SidorovaCentro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBER-EHD), Madrid, Spain.
Beatriz LoboLaboratory of Neuro-immuno-gastroenterology, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
Carmen Alonso-CotonerLaboratory of Neuro-immuno-gastroenterology, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
Elba ExpositoLaboratory of Neuro-immuno-gastroenterology, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
Alfredo J LucendoCentro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBER-EHD), Madrid, Spain.ORCID https://orcid.org/0000-0003-1183-1072
Stefania LandolfiPathology Department, University Hospital Vall d'Hebron, Barcelona, Spain.
Ana BenagesEndoscopy Department, University Hospital Vall d'Hebron, Barcelona, Spain.
Ronald Llerena-CastroGastroenterology Department, University Hospital Vall d'Hebron, Barcelona, Spain.
Maria Dolores Castillo CejasEndoscopy Department, University Hospital Vall d'Hebron, Barcelona, Spain.ORCID https://orcid.org/0009-0002-0838-4291
Joan DotEndoscopy Department, University Hospital Vall d'Hebron, Barcelona, Spain.
Javier SantosLaboratory of Neuro-immuno-gastroenterology, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
Maria VicarioLaboratory of Translational Mucosal Immunology, Vall d'Hebron Institut de Recerca, Barcelona, Spain.

Funding

AEG Foundation Gonzalo MiñoCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas ACCES-16 Phase IIILinköpings Universitet Microvilli in microscopic colitissan carlos III PI17/01443san carlos III PI19/01643
6 · The paper itself

Abstract

backgroundMicroscopic colitis (MC), comprising lymphocytic colitis (LC) and collagenous colitis (CC), is an inflammatory bowel disease with increasing incidence. MC etiopathogenesis remains unknown; however, altered colonic epithelial integrity may underlie uncontrolled luminal antigen passage, triggering immuno-inflammatory responses.

objectiveThe aim of this study was to further define the involvement of the colonic epithelium in MC.

methodsA paired transcriptomic and proteomic analysis followed by epithelial ultrastructural examination was performed on colonic biopsies from LC and CC patients, and from irritable bowel syndrome with a predominance of diarrhoea (IBS-D) and healthy subjects (H) as control groups. The impact of budesonide therapy on the epithelial structure was also evaluated in CC.

resultsMC patients exhibited decreased expression of inter-microvilli adhesion and actin-bundling proteins, accompanied by increased expression of actin-membrane connection proteins compared to both control groups. Distinct molecular differentiated CC and LC, which translated into differential ultrastructure abnormalities. The colonic microvilli in CC patients were shorter in length and fewer in number, with partial restoration following budesonide treatment, whereas LC showed a reduction solely in microvilli number. A negative correlation was found between daily stool frequency and SPATN1 and ATP8B1 protein levels in CC patients.

conclusionsMolecular dysregulation and aberrant ultrastructure of the colonic brush border feature the colonic epithelium in LC and CC. These previously undescribed findings provide new perspectives for further defining MC pathogenesis and identifying biomarkers for diagnosis, prognosis and treatment of this debilitating and prevalent disease.

Indexed as

Colitis, CollagenousColitis, LymphocyticColitis, MicroscopicColonIntestinal MucosaMicrovilliAdultAgedBiopsyBudesonideCase-Control StudiesFemaleGene Expression ProfilingHumansIrritable Bowel SyndromeMaleBudesonidebrush bordercollagenous colitislymphocytic colitismicroscopic colitismicrovilli

Identifiers

PMID41442229
PMCPMC12781189

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.